Business Context and Reporting Period
Company: Faraday Future Intelligent Electric Inc. (FFAI)
Filing Type: Form 10-Q (Unaudited)
Period Ended: June 30, 2026
Business Overview: The Company operates three segments: AI Electric Vehicles (AIEV), Robotics, and AIXC (digital assets and real-world asset tokenization). It is currently manufacturing the FF 91, developing the FF 92 and FX Super One, and commercializing embodied AI robotics products. The Company consolidated AIXC as a Variable Interest Entity (VIE) in September 2025.
Key Financial Metrics (Six Months Ended June 30, 2026)
| Metric | Amount (in thousands) |
|---|---|
| Revenue | $1,348 |
| Cost of Revenue | $23,428 |
| Gross Profit (Loss) | $(22,080) |
| Net Loss | $(81,280) |
| Net Loss Attributable to FFAI | $(74,885) |
| Net Loss Per Share (Basic & Diluted) | $(42.74) |
| Cash and Cash Equivalents | $11,196 |
| Restricted Cash | $42,689 |
| Total Assets | $279,802 |
| Total Liabilities | $278,390 |
| Stockholders' Equity | $1,412 |
| Accumulated Deficit | $(4,779,927) |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 264% to $1.35 million (from $0.37 million in 2025), driven primarily by $1.14 million in Robotics revenue. AIEV revenue decreased slightly to $0.21 million.
- Operating Loss Improvement: Loss from operations improved to $(70.7) million from $(91.9) million in the prior year, largely due to reduced depreciation and inventory reserve expenses following a significant impairment in Q3 2025.
- Impairment Charges: The Company recorded $5.7 million in impairment of intangible assets and goodwill, primarily related to the AIXC acquisition (wind-down of legacy biotech IPR&D and goodwill impairment).
- Debt Settlement Losses: Loss on settlement of notes payable decreased significantly to $(16.3) million from $(38.4) million, attributed to a lower average loss rate on conversions as the stock price approached conversion floors.
- Digital Assets: Net loss on digital assets of $(2.9) million was recorded, a new line item resulting from the consolidation of AIXC.
Guidance, Outlook, Risks, and Unusual Items
Going Concern Warning
Management has concluded that substantial doubt exists regarding the Company's ability to continue as a going concern for one year following the issuance of these financial statements. This is due to recurring operating losses, an accumulated deficit of $4.78 billion, and a working capital deficit of $83.8 million (excluding restricted cash).
Liquidity and Capital Resources
- Restricted Cash: Approximately $42.7 million of cash is restricted under deposit account control agreements and is generally unavailable for ordinary operations.
- Financing Activities: The Company raised $76.4 million in net cash from financing activities, including $45.0 million from Secured Streeterville Notes and $25.0 million from 2026 May Convertible SPA Notes.
- ATM Program: A replacement Form S-3 registration statement became effective on July 24, 2026. Subsequent to the period end, the Company sold 163,174 shares for approximately $1.0 million.
Unusual Items and Risks
- Reverse Stock Split: A 1-for-150 reverse stock split was effected on July 24, 2026, to address Nasdaq minimum bid price compliance. All share data in the filing is retroactively adjusted.
- Legal Proceedings: The Company is subject to various lawsuits, including claims from former employees and suppliers. The SEC investigation regarding 2021 disclosures concluded in March 2026 with no enforcement action recommended.
- Regulatory Risks: New FCC rules regarding foreign-produced advanced robotic devices may impact future robotics imports and sales in the U.S.
- Debt Structure: The Company carries significant convertible debt with full-ratchet anti-dilution provisions, which have triggered multiple conversion price resets during the period.
Investor Verification Checklist
- Going Concern Status: Verify the Company's ability to secure additional funding beyond current restricted cash and committed SPA facilities to meet obligations within the next 12 months.
- Restricted Cash Utilization: Confirm the specific release conditions for the $42.7 million in restricted cash and whether it can be accessed for operational liquidity.
- Debt Conversion Terms: Review the impact of full-ratchet anti-dilution provisions on future equity dilution, given the recent conversion price resets.
- Robotics Commercialization: Assess the sustainability of Robotics revenue growth and the impact of new FCC regulations on the supply chain and U.S. market entry.
- Nasdaq Compliance: Monitor the post-split stock price to ensure continued compliance with Nasdaq listing requirements.